Global Kidney Fibrosis Treatment Market Research Report 2024

Industry: Medical Care

Published: 2024-01-04

Pages: 78 Pages

Report ld: 2134985

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.

The global Kidney Fibrosis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Kidney Fibrosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Fibrosis Treatment.

Report Scope
The Kidney Fibrosis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Kidney Fibrosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Kidney Fibrosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Report Metric
Details
Report Title
Global Kidney Fibrosis Treatment Market Research Report 2024
Market Size Available for Years
2024-2030
Global Kidney Fibrosis Treatment Companies Covered
Merck and Co(US)
Pfizer Inc(US)
F. Hoffman-La Roche(Switzerland)
InterMune Inc(US)
Galectin Therapeutics(US)
La Jolla Pharmaceutical Company(US)
ProMetic Life-Sciences Inc(Canada)
BioLine Rx(Israel)
Genzyme Corporation(US)
Global Kidney Fibrosis Treatment Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Kidney Fibrosis Treatment Market, Segment by Type
Angiotensin Converting Enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Vasopeptidase Inhibitors
Global Kidney Fibrosis Treatment Market, Segment by Application
Chronic Kidney Diseases
Kidney Cancer Treatment
Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney Fibrosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Kidney Fibrosis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
        1.2.2 Angiotensin Converting Enzyme (ACE) Inhibitors
        1.2.3 Pirfenidone
        1.2.4 Renin Inhibitors
        1.2.5 Angiotensin II Receptor Blockers (ARBs)
        1.2.6 Vasopeptidase Inhibitors
    1.3 Market by Application
        1.3.1 Global Kidney Fibrosis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
        1.3.2 Chronic Kidney Diseases
        1.3.3 Kidney Cancer Treatment
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Kidney Fibrosis Treatment Market Perspective (2019-2030)
    2.2 Kidney Fibrosis Treatment Growth Trends by Region
        2.2.1 Global Kidney Fibrosis Treatment Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Kidney Fibrosis Treatment Historic Market Size by Region (2019-2024)
        2.2.3 Kidney Fibrosis Treatment Forecasted Market Size by Region (2025-2030)
    2.3 Kidney Fibrosis Treatment Market Dynamics
        2.3.1 Kidney Fibrosis Treatment Industry Trends
        2.3.2 Kidney Fibrosis Treatment Market Drivers
        2.3.3 Kidney Fibrosis Treatment Market Challenges
        2.3.4 Kidney Fibrosis Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Kidney Fibrosis Treatment Players by Revenue
        3.1.1 Global Top Kidney Fibrosis Treatment Players by Revenue (2019-2024)
        3.1.2 Global Kidney Fibrosis Treatment Revenue Market Share by Players (2019-2024)
    3.2 Global Kidney Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Kidney Fibrosis Treatment Revenue
    3.4 Global Kidney Fibrosis Treatment Market Concentration Ratio
        3.4.1 Global Kidney Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Kidney Fibrosis Treatment Revenue in 2023
    3.5 Kidney Fibrosis Treatment Key Players Head office and Area Served
    3.6 Key Players Kidney Fibrosis Treatment Product Solution and Service
    3.7 Date of Enter into Kidney Fibrosis Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Kidney Fibrosis Treatment Breakdown Data by Type
    4.1 Global Kidney Fibrosis Treatment Historic Market Size by Type (2019-2024)
    4.2 Global Kidney Fibrosis Treatment Forecasted Market Size by Type (2025-2030)

5 Kidney Fibrosis Treatment Breakdown Data by Application
    5.1 Global Kidney Fibrosis Treatment Historic Market Size by Application (2019-2024)
    5.2 Global Kidney Fibrosis Treatment Forecasted Market Size by Application (2025-2030)

6 North America
    6.1 North America Kidney Fibrosis Treatment Market Size (2019-2030)
    6.2 North America Kidney Fibrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
    6.3 North America Kidney Fibrosis Treatment Market Size by Country (2019-2024)
    6.4 North America Kidney Fibrosis Treatment Market Size by Country (2025-2030)
    6.5 United States
    6.6 Canada

7 Europe
    7.1 Europe Kidney Fibrosis Treatment Market Size (2019-2030)
    7.2 Europe Kidney Fibrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
    7.3 Europe Kidney Fibrosis Treatment Market Size by Country (2019-2024)
    7.4 Europe Kidney Fibrosis Treatment Market Size by Country (2025-2030)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

8 Asia-Pacific
    8.1 Asia-Pacific Kidney Fibrosis Treatment Market Size (2019-2030)
    8.2 Asia-Pacific Kidney Fibrosis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
    8.3 Asia-Pacific Kidney Fibrosis Treatment Market Size by Region (2019-2024)
    8.4 Asia-Pacific Kidney Fibrosis Treatment Market Size by Region (2025-2030)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

9 Latin America
    9.1 Latin America Kidney Fibrosis Treatment Market Size (2019-2030)
    9.2 Latin America Kidney Fibrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
    9.3 Latin America Kidney Fibrosis Treatment Market Size by Country (2019-2024)
    9.4 Latin America Kidney Fibrosis Treatment Market Size by Country (2025-2030)
    9.5 Mexico
    9.6 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Kidney Fibrosis Treatment Market Size (2019-2030)
    10.2 Middle East & Africa Kidney Fibrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
    10.3 Middle East & Africa Kidney Fibrosis Treatment Market Size by Country (2019-2024)
    10.4 Middle East & Africa Kidney Fibrosis Treatment Market Size by Country (2025-2030)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

11 Key Players Profiles
    11.1 Merck and Co(US)
        11.1.1 Merck and Co(US) Company Detail
        11.1.2 Merck and Co(US) Business Overview
        11.1.3 Merck and Co(US) Kidney Fibrosis Treatment Introduction
        11.1.4 Merck and Co(US) Revenue in Kidney Fibrosis Treatment Business (2019-2024)
        11.1.5 Merck and Co(US) Recent Development
    11.2 Pfizer Inc(US)
        11.2.1 Pfizer Inc(US) Company Detail
        11.2.2 Pfizer Inc(US) Business Overview
        11.2.3 Pfizer Inc(US) Kidney Fibrosis Treatment Introduction
        11.2.4 Pfizer Inc(US) Revenue in Kidney Fibrosis Treatment Business (2019-2024)
        11.2.5 Pfizer Inc(US) Recent Development
    11.3 F. Hoffman-La Roche(Switzerland)
        11.3.1 F. Hoffman-La Roche(Switzerland) Company Detail
        11.3.2 F. Hoffman-La Roche(Switzerland) Business Overview
        11.3.3 F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Introduction
        11.3.4 F. Hoffman-La Roche(Switzerland) Revenue in Kidney Fibrosis Treatment Business (2019-2024)
        11.3.5 F. Hoffman-La Roche(Switzerland) Recent Development
    11.4 InterMune Inc(US)
        11.4.1 InterMune Inc(US) Company Detail
        11.4.2 InterMune Inc(US) Business Overview
        11.4.3 InterMune Inc(US) Kidney Fibrosis Treatment Introduction
        11.4.4 InterMune Inc(US) Revenue in Kidney Fibrosis Treatment Business (2019-2024)
        11.4.5 InterMune Inc(US) Recent Development
    11.5 Galectin Therapeutics(US)
        11.5.1 Galectin Therapeutics(US) Company Detail
        11.5.2 Galectin Therapeutics(US) Business Overview
        11.5.3 Galectin Therapeutics(US) Kidney Fibrosis Treatment Introduction
        11.5.4 Galectin Therapeutics(US) Revenue in Kidney Fibrosis Treatment Business (2019-2024)
        11.5.5 Galectin Therapeutics(US) Recent Development
    11.6 La Jolla Pharmaceutical Company(US)
        11.6.1 La Jolla Pharmaceutical Company(US) Company Detail
        11.6.2 La Jolla Pharmaceutical Company(US) Business Overview
        11.6.3 La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Introduction
        11.6.4 La Jolla Pharmaceutical Company(US) Revenue in Kidney Fibrosis Treatment Business (2019-2024)
        11.6.5 La Jolla Pharmaceutical Company(US) Recent Development
    11.7 ProMetic Life-Sciences Inc(Canada)
        11.7.1 ProMetic Life-Sciences Inc(Canada) Company Detail
        11.7.2 ProMetic Life-Sciences Inc(Canada) Business Overview
        11.7.3 ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Introduction
        11.7.4 ProMetic Life-Sciences Inc(Canada) Revenue in Kidney Fibrosis Treatment Business (2019-2024)
        11.7.5 ProMetic Life-Sciences Inc(Canada) Recent Development
    11.8 BioLine Rx(Israel)
        11.8.1 BioLine Rx(Israel) Company Detail
        11.8.2 BioLine Rx(Israel) Business Overview
        11.8.3 BioLine Rx(Israel) Kidney Fibrosis Treatment Introduction
        11.8.4 BioLine Rx(Israel) Revenue in Kidney Fibrosis Treatment Business (2019-2024)
        11.8.5 BioLine Rx(Israel) Recent Development
    11.9 Genzyme Corporation(US)
        11.9.1 Genzyme Corporation(US) Company Detail
        11.9.2 Genzyme Corporation(US) Business Overview
        11.9.3 Genzyme Corporation(US) Kidney Fibrosis Treatment Introduction
        11.9.4 Genzyme Corporation(US) Revenue in Kidney Fibrosis Treatment Business (2019-2024)
        11.9.5 Genzyme Corporation(US) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Table of Figures

List of Tables
    Table 1. Global Kidney Fibrosis Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors
    Table 3. Key Players of Pirfenidone
    Table 4. Key Players of Renin Inhibitors
    Table 5. Key Players of Angiotensin II Receptor Blockers (ARBs)
    Table 6. Key Players of Vasopeptidase Inhibitors
    Table 7. Global Kidney Fibrosis Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Kidney Fibrosis Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Kidney Fibrosis Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Kidney Fibrosis Treatment Market Share by Region (2019-2024)
    Table 11. Global Kidney Fibrosis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Kidney Fibrosis Treatment Market Share by Region (2025-2030)
    Table 13. Kidney Fibrosis Treatment Market Trends
    Table 14. Kidney Fibrosis Treatment Market Drivers
    Table 15. Kidney Fibrosis Treatment Market Challenges
    Table 16. Kidney Fibrosis Treatment Market Restraints
    Table 17. Global Kidney Fibrosis Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Kidney Fibrosis Treatment Market Share by Players (2019-2024)
    Table 19. Global Top Kidney Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Fibrosis Treatment as of 2023)
    Table 20. Ranking of Global Top Kidney Fibrosis Treatment Companies by Revenue (US$ Million) in 2023
    Table 21. Global 5 Largest Players Market Share by Kidney Fibrosis Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Kidney Fibrosis Treatment Product Solution and Service
    Table 24. Date of Enter into Kidney Fibrosis Treatment Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Kidney Fibrosis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Kidney Fibrosis Treatment Revenue Market Share by Type (2019-2024)
    Table 28. Global Kidney Fibrosis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Kidney Fibrosis Treatment Revenue Market Share by Type (2025-2030)
    Table 30. Global Kidney Fibrosis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Kidney Fibrosis Treatment Revenue Market Share by Application (2019-2024)
    Table 32. Global Kidney Fibrosis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Kidney Fibrosis Treatment Revenue Market Share by Application (2025-2030)
    Table 34. North America Kidney Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. North America Kidney Fibrosis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 36. North America Kidney Fibrosis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Europe Kidney Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Europe Kidney Fibrosis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 39. Europe Kidney Fibrosis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Asia-Pacific Kidney Fibrosis Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Asia-Pacific Kidney Fibrosis Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 42. Asia-Pacific Kidney Fibrosis Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 43. Latin America Kidney Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Latin America Kidney Fibrosis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Latin America Kidney Fibrosis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Middle East & Africa Kidney Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Middle East & Africa Kidney Fibrosis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Middle East & Africa Kidney Fibrosis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 49. Merck and Co(US) Company Detail
    Table 50. Merck and Co(US) Business Overview
    Table 51. Merck and Co(US) Kidney Fibrosis Treatment Product
    Table 52. Merck and Co(US) Revenue in Kidney Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 53. Merck and Co(US) Recent Development
    Table 54. Pfizer Inc(US) Company Detail
    Table 55. Pfizer Inc(US) Business Overview
    Table 56. Pfizer Inc(US) Kidney Fibrosis Treatment Product
    Table 57. Pfizer Inc(US) Revenue in Kidney Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 58. Pfizer Inc(US) Recent Development
    Table 59. F. Hoffman-La Roche(Switzerland) Company Detail
    Table 60. F. Hoffman-La Roche(Switzerland) Business Overview
    Table 61. F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Product
    Table 62. F. Hoffman-La Roche(Switzerland) Revenue in Kidney Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 63. F. Hoffman-La Roche(Switzerland) Recent Development
    Table 64. InterMune Inc(US) Company Detail
    Table 65. InterMune Inc(US) Business Overview
    Table 66. InterMune Inc(US) Kidney Fibrosis Treatment Product
    Table 67. InterMune Inc(US) Revenue in Kidney Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 68. InterMune Inc(US) Recent Development
    Table 69. Galectin Therapeutics(US) Company Detail
    Table 70. Galectin Therapeutics(US) Business Overview
    Table 71. Galectin Therapeutics(US) Kidney Fibrosis Treatment Product
    Table 72. Galectin Therapeutics(US) Revenue in Kidney Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 73. Galectin Therapeutics(US) Recent Development
    Table 74. La Jolla Pharmaceutical Company(US) Company Detail
    Table 75. La Jolla Pharmaceutical Company(US) Business Overview
    Table 76. La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Product
    Table 77. La Jolla Pharmaceutical Company(US) Revenue in Kidney Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 78. La Jolla Pharmaceutical Company(US) Recent Development
    Table 79. ProMetic Life-Sciences Inc(Canada) Company Detail
    Table 80. ProMetic Life-Sciences Inc(Canada) Business Overview
    Table 81. ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Product
    Table 82. ProMetic Life-Sciences Inc(Canada) Revenue in Kidney Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 83. ProMetic Life-Sciences Inc(Canada) Recent Development
    Table 84. BioLine Rx(Israel) Company Detail
    Table 85. BioLine Rx(Israel) Business Overview
    Table 86. BioLine Rx(Israel) Kidney Fibrosis Treatment Product
    Table 87. BioLine Rx(Israel) Revenue in Kidney Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 88. BioLine Rx(Israel) Recent Development
    Table 89. Genzyme Corporation(US) Company Detail
    Table 90. Genzyme Corporation(US) Business Overview
    Table 91. Genzyme Corporation(US) Kidney Fibrosis Treatment Product
    Table 92. Genzyme Corporation(US) Revenue in Kidney Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 93. Genzyme Corporation(US) Recent Development
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Kidney Fibrosis Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Kidney Fibrosis Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Angiotensin Converting Enzyme (ACE) Inhibitors Features
    Figure 4. Pirfenidone Features
    Figure 5. Renin Inhibitors Features
    Figure 6. Angiotensin II Receptor Blockers (ARBs) Features
    Figure 7. Vasopeptidase Inhibitors Features
    Figure 8. Global Kidney Fibrosis Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Kidney Fibrosis Treatment Market Share by Application: 2023 VS 2030
    Figure 10. Chronic Kidney Diseases Case Studies
    Figure 11. Kidney Cancer Treatment Case Studies
    Figure 12. Others Case Studies
    Figure 13. Kidney Fibrosis Treatment Report Years Considered
    Figure 14. Global Kidney Fibrosis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Kidney Fibrosis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Kidney Fibrosis Treatment Market Share by Region: 2023 VS 2030
    Figure 17. Global Kidney Fibrosis Treatment Market Share by Players in 2023
    Figure 18. Global Top Kidney Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Fibrosis Treatment as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Kidney Fibrosis Treatment Revenue in 2023
    Figure 20. North America Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Kidney Fibrosis Treatment Market Share by Country (2019-2030)
    Figure 22. United States Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Kidney Fibrosis Treatment Market Share by Country (2019-2030)
    Figure 26. Germany Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Kidney Fibrosis Treatment Market Share by Region (2019-2030)
    Figure 34. China Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Kidney Fibrosis Treatment Market Share by Country (2019-2030)
    Figure 42. Mexico Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Kidney Fibrosis Treatment Market Share by Country (2019-2030)
    Figure 46. Turkey Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Kidney Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Merck and Co(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2019-2024)
    Figure 49. Pfizer Inc(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2019-2024)
    Figure 50. F. Hoffman-La Roche(Switzerland) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2019-2024)
    Figure 51. InterMune Inc(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2019-2024)
    Figure 52. Galectin Therapeutics(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2019-2024)
    Figure 53. La Jolla Pharmaceutical Company(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2019-2024)
    Figure 54. ProMetic Life-Sciences Inc(Canada) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2019-2024)
    Figure 55. BioLine Rx(Israel) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2019-2024)
    Figure 56. Genzyme Corporation(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2019-2024)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed

Description

Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.

The global Kidney Fibrosis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney Fibrosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Related Reports

Global Kidney Fibrosis Treatment Market Research Report 2023
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2023-06-11
Pages: 85
USD 2900.00
(Single User License)
Global Kidney Fibrosis Treatment Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2023-05-30
Pages: 102
USD 5600.00
(Single User License)
Global Kidney Fibrosis Treatment Market Insights, Forecast to 2029
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2023-05-31
Pages: 91
USD 4900.00
(Single User License)
Global Kidney Fibrosis Treatment Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2023-05-30
Pages: 88
USD 3350.00
(Single User License)
Kidney Fibrosis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2024-01-24
Pages: 92
USD 3950.00
(Single User License)
Global Kidney Fibrosis Treatment Market Insights, Forecast to 2030
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2024-04-28
Pages: 88
USD 4900.00
(Single User License)
Global Kidney Fibrosis Treatment Market Research Report 2025
The global market for Kidney Fibrosis Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-27
Pages: 71
USD 2900.00
(Single User License)
Kidney Fibrosis Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Kidney Fibrosis Treatment was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 89
USD 3950.00
(Single User License)